Shanta Bantia

2.9k total citations · 1 hit paper
57 papers, 2.3k citations indexed

About

Shanta Bantia is a scholar working on Molecular Biology, Epidemiology and Genetics. According to data from OpenAlex, Shanta Bantia has authored 57 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 24 papers in Epidemiology and 14 papers in Genetics. Recurrent topics in Shanta Bantia's work include Biochemical and Molecular Research (28 papers), Influenza Virus Research Studies (14 papers) and Adenosine and Purinergic Signaling (13 papers). Shanta Bantia is often cited by papers focused on Biochemical and Molecular Research (28 papers), Influenza Virus Research Studies (14 papers) and Adenosine and Purinergic Signaling (13 papers). Shanta Bantia collaborates with scholars based in United States, United Kingdom and Australia. Shanta Bantia's co-authors include Y.S. Babu, Pravin L. Kotian, Pooran Chand, Cynthia Parker, John A. Montgomery, Sandya L. Ananth, Yahya El-Kattan, Tracy L. Hutchison, Ramanda Upshaw and Tsu‐Hsing Lin and has published in prestigious journals such as Nature, Blood and Journal of Molecular Biology.

In The Last Decade

Shanta Bantia

55 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430

2014 461 citations Travis K. Warren, Jay Wells et al. Nature profile →

Peers

Countries citing papers authored by Shanta Bantia

Since Specialization

Citations

This map shows the geographic impact of Shanta Bantia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanta Bantia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanta Bantia more than expected).

Fields of papers citing papers by Shanta Bantia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shanta Bantia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanta Bantia. The network helps show where Shanta Bantia may publish in the future.

Co-authorship network of co-authors of Shanta Bantia

This figure shows the co-authorship network connecting the top 25 collaborators of Shanta Bantia. A scholar is included among the top collaborators of Shanta Bantia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shanta Bantia. Shanta Bantia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Treatment duration with immune-based therapies in Cancer: an enigma 2018 ·Journal for ImmunoTherapy of Cancer ·Shanta Bantia, (unknown)	13
2	Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430 breakdown → 2014 ·Nature ·Travis K. Warren, Jay Wells, Rekha G. Panchal, Kelly S. Stuthman, Nicole L. Garza, Sean A. Van Tongeren, Lián Dŏng, Cary Retterer, Brett Eaton, Gianluca Pegoraro, Shelley P. Honnold, Shanta Bantia, Pravin L. Kotian, Xilin Chen, (unknown), Lisa S. Welch, Dena M. Minning, Y.S. Babu, William Sheridan, Sina Bavari	461
3	Characterization of the binding affinities of peramivir and oseltamivir carboxylate to the neuraminidase enzyme 2011 ·Antiviral Research ·Shanta Bantia, Ramanda Upshaw, Y.S. Babu	14
4	Combination of peramivir and rimantadine demonstrate synergistic antiviral effects in sub-lethal influenza A (H3N2) virus mouse model 2010 ·Antiviral Research ·Shanta Bantia, (unknown), Cynthia Parker, Y.S. Babu	26
5	Potent orally bioavailable purine nucleoside phosphorylase inhibitor BCX-4208 induces apoptosis in B- and T-lymphocytes—A novel treatment approach for autoimmune diseases, organ transplantation and hematologic malignancies 2010 ·International Immunopharmacology ·Shanta Bantia, Cynthia Parker, Ramanda Upshaw, (unknown), Pravin L. Kotian, J. Michael Kilpatrick, Phillip Morris, Pooran Chand, Y.S. Babu	25
6	Design, parallel synthesis, and crystal structures of biphenyl antithrombotics as selective inhibitors of tissue factor FVIIa complex. Part 1: Exploration of S2 pocket pharmacophores 2009 ·Bioorganic & Medicinal Chemistry ·Pravin L. Kotian, (unknown), (unknown), Yahya El-Kattan, Surendra Kumar Saini, Ramanda Upshaw, Shanta Bantia, (unknown), Y.S. Babu, Pooran Chand	10
7	The purine nucleoside phosphorylase inhibitor forodesine induces p53-independent apoptosis in chronic lymphocytic leukemia through caspase-8 activation, Mcl-1 downregulation, conformational changes of Bax and Bak and ROS generation. 2007 ·Molecular Cancer Therapeutics ·Roberto Alonso, Neus Villamor, Ramanda Upshaw, Shanta Bantia, Thomas Mehrling, Elı́as Campo, Emili Montserrat, Dolors Colomer	2
8	An Efficient Synthesis Of Acyclic N⁷- and N⁹-Adenine Nucleosides Via Alkylation With Secondary Carbon Electrophiles to Introduce Versatile Functional Groups At the C-1 Position of Acyclic Moiety 2006 ·Nucleosides Nucleotides & Nucleic Acids ·Pravin L. Kotian, V.B. Sameer Kumar, Tsu‐Hsing Lin, Yahya El-Kattan, Ajit Ghosh, (unknown), Xiaogang Cheng, Shanta Bantia, Y.S. Babu, Pooran Chand	4
9	Discovery of Highly Potent Small Molecule Kallikrein Inhibitors 2006 ·Medicinal Chemistry ·(unknown), (unknown), (unknown), Eva Mattsson, J. Michael Kilpatrick, Shanta Bantia, Ali Dehghani, (unknown), (unknown), Pravin L. Kotian, Pooran Chand, Y.S. Babu	7
10	Comparison of the anti-influenza virus activity of cyclopentane derivatives with oseltamivir and zanamivir in vivo 2005 ·Bioorganic & Medicinal Chemistry ·Pooran Chand, Shanta Bantia, Pravin L. Kotian, Yahya El-Kattan, Tsu‐Hsing Lin, Y.S. Babu	49
11	Anti-influenza virus activity of peramivir in mice with single intramuscular injection 2005 ·Antiviral Research ·Shanta Bantia, (unknown), Cynthia Parker, Ramanda Upshaw, Pooran Chand	120
12	Intravenous Forodesine (BCX-1777), a Novel Purine Nucleoside Phosphorylase (PNP) Inhibitor, Demonstrates Clinical Activity in Patients with Refractory Cutaneous T-Cell Lymphoma. 2004 ·Blood ·Madeleine Duvic, Francine M. Foss, Elise A. Olsen, Andres Forero‐Torres, John Bennett, Shanta Bantia, J. Michael Kilpatrick	15
13	Antileukemic Activity and Pharmacodynamics of Intravenous Forodesine (BCX-1777), a Novel Purine Nucleoside Phosphorylase (PNP) Inhibitor, in Phase I/II Trials in Patients with Advanced T-Cell Malignancies. 2004 ·Blood ·Luis Isola, Richard R. Furman, Varsha Gandhi, Deborah A. Thomas, John Bennett, Shanta Bantia, J. Michael Kilpatrick	11
14	Purine nucleoside phosphorylase inhibitors in T-cell malignancies. 2004 ·PubMed ·Shanta Bantia, John Michael Kilpatrick	29
15	Mechanism of inhibition of T-acute lymphoblastic leukemia cells by PNP inhibitor—BCX-1777 2003 ·International Immunopharmacology ·Shanta Bantia, Sandya L. Ananth, Cynthia Parker, (unknown), Ramanda Upshaw	63
16	Hydrophobic benzoic acids as inhibitors of influenza neuraminidase 1999 ·Bioorganic & Medicinal Chemistry ·Venkatram R. Atigadda, Wayne J. Brouillette, (unknown), Y.S. Babu, Shanta Bantia, Pooran Chand, (unknown), John A. Montgomery, David A. Walsh, E. Sudbeck, (unknown), Gillian M. Air, Ming Luo, Graeme Laver	26
17	Design of benzoic acid inhibitors of influenza neuraminidase containing a cyclic substitution for the N-acetyl grouping 1999 ·Bioorganic & Medicinal Chemistry Letters ·Wayne J. Brouillette, Venkatram R. Atigadda, Ming Luo, Gillian M. Air, Y.S. Babu, Shanta Bantia	23
18	Effects of a novel purine nucleoside phosphorylase inhibitor, BCX-34, on activation and proliferation of normal human lymphoid cells 1998 ·Immunopharmacology ·Robert M. Conry, Shanta Bantia, (unknown), D L Barlow, Karen O. Allen, (unknown), John A. Montgomery, Gerald M. Walsh	15
19	Guanidinobenzoic acid inhibitors of influenza virus neuraminidase 1 1Edited by R. Huber 1997 ·Journal of Molecular Biology ·E. Sudbeck, M.J. Jedrzejas, Sangeeta Singh, Wayne J. Brouillette, Gillian M. Air, W.G. Laver, Y.S. Babu, Shanta Bantia, Pooran Chand, (unknown), John A. Montgomery, David A. Walsh, Ming Luo	31
20	In vivo and in vitro pharmacologic activity of the purine nucleoside phosphorylase inhibitor BCX-34: the role of GTP and dGTP 1996 ·Immunopharmacology ·Shanta Bantia, John A. Montgomery, Harry G. Johnson, Gerald M. Walsh	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact